BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38676803)

  • 1. Patient-Derived Xenograft Models for Ovarian Cancer.
    Tran TM; Ho GY; Chu S
    Methods Mol Biol; 2024; 2806():187-196. PubMed ID: 38676803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of an ovarian yolk sac tumor patient-derived xenograft model.
    Luo M; He Y; Xie B; Li S; Gan F; Zhang S; Luo P
    Pediatr Surg Int; 2021 Aug; 37(8):1031-1040. PubMed ID: 34031745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics.
    Liu JF; Palakurthi S; Zeng Q; Zhou S; Ivanova E; Huang W; Zervantonakis IK; Selfors LM; Shen Y; Pritchard CC; Zheng M; Adleff V; Papp E; Piao H; Novak M; Fotheringham S; Wulf GM; English J; Kirschmeier PT; Velculescu VE; Paweletz C; Mills GB; Livingston DM; Brugge JS; Matulonis UA; Drapkin R
    Clin Cancer Res; 2017 Mar; 23(5):1263-1273. PubMed ID: 27573169
    [No Abstract]   [Full Text] [Related]  

  • 4. Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model.
    Oda Y; Niimi K; Yoshida K; Tamauchi S; Yokoi A; Yasui Y; Nishiko Y; Shibata M; Shimizu Y; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Yamamoto E; Kajiyama H
    BMC Cancer; 2023 Nov; 23(1):1103. PubMed ID: 37957624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.
    Prasetyanti PR; van Hooff SR; van Herwaarden T; de Vries N; Kalloe K; Rodermond H; van Leersum R; de Jong JH; Franitza M; Nürnberg P; Todaro M; Stassi G; Medema JP
    Int J Cancer; 2019 Jan; 144(2):366-371. PubMed ID: 30151914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies.
    Heo EJ; Cho YJ; Cho WC; Hong JE; Jeon HK; Oh DY; Choi YL; Song SY; Choi JJ; Bae DS; Lee YY; Choi CH; Kim TJ; Park WY; Kim BG; Lee JW
    Cancer Res Treat; 2017 Oct; 49(4):915-926. PubMed ID: 28052650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of ovarian cancer cell lines as in vivo models for preclinical studies.
    Hernandez L; Kim MK; Lyle LT; Bunch KP; House CD; Ning F; Noonan AM; Annunziata CM
    Gynecol Oncol; 2016 Aug; 142(2):332-40. PubMed ID: 27235858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanized Patient-Derived Xenograft Models of Ovarian Cancer.
    Gitto SB; George E; Medvedev S; Simpkins F; Powell DJ
    Methods Mol Biol; 2022; 2424():255-274. PubMed ID: 34918300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer.
    Gitto SB; Kim H; Rafail S; Omran DK; Medvedev S; Kinose Y; Rodriguez-Garcia A; Flowers AJ; Xu H; Schwartz LE; Powell DJ; Simpkins F
    Gynecol Oncol; 2020 Jan; 156(1):222-232. PubMed ID: 31818495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Derived Xenograft Models in Breast Cancer Research.
    Na D; Moon HG
    Adv Exp Med Biol; 2021; 1187():283-301. PubMed ID: 33983584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
    Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
    Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model.
    Vaeteewoottacharn K; Pairojkul C; Kariya R; Muisuk K; Imtawil K; Chamgramol Y; Bhudhisawasdi V; Khuntikeo N; Pugkhem A; Saeseow OT; Silsirivanit A; Wongkham C; Wongkham S; Okada S
    Cells; 2019 May; 8(5):. PubMed ID: 31126020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer.
    Scherer SD; Riggio AI; Haroun F; DeRose YS; Ekiz HA; Fujita M; Toner J; Zhao L; Li Z; Oesterreich S; Samatar AA; Welm AL
    Breast Cancer Res; 2021 Oct; 23(1):100. PubMed ID: 34717714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Humanized Patient-Derived Xenograft Model for Pancreatic Cancer.
    Lundy J
    Methods Mol Biol; 2024; 2806():91-100. PubMed ID: 38676798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment.
    Wang L; Chen H; Fei F; He X; Sun S; Lv K; Yu B; Long J; Wang X
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31107449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to Success.
    Eguchi S; Kimura K; Kageyama K; Tani N; Tanaka R; Nishio K; Shinkawa H; Ohira GO; Amano R; Tanaka S; Yamamoto A; Takemura S; Yashiro M; Kubo S
    Anticancer Res; 2022 May; 42(5):2395-2404. PubMed ID: 35489770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.
    Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C
    Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Expansion of Patient-Derived Xenografts for Endometrial Cancer.
    Sengal AT; Pollock PM
    Methods Mol Biol; 2024; 2806():101-115. PubMed ID: 38676799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-derived xenograft (PDX) models, applications and challenges in cancer research.
    Abdolahi S; Ghazvinian Z; Muhammadnejad S; Saleh M; Asadzadeh Aghdaei H; Baghaei K
    J Transl Med; 2022 May; 20(1):206. PubMed ID: 35538576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma.
    Liu Z; Ahn MH; Kurokawa T; Ly A; Zhang G; Wang F; Yamada T; Sadagopan A; Cheng J; Ferrone CR; Liss AS; Honselmann KC; Wojtkiewicz GR; Ferrone S; Wang X
    J Transl Med; 2020 Jun; 18(1):255. PubMed ID: 32580742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.